null - FindTrial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2015-000468-33-FR

Enrollment

142

Registered

2015-07-24

Start date

2015-08-25

Completion date

Unknown

Last updated

2021-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Kénacort Retard Product Name: Kénacort Retard Pharmaceutical Form: Suspension for injection INN or Proposed INN: TRIAMCINOLONE ACETONIDE Concentration unit: mg/ml milligram(s)/millilitre C

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 95 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 47

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Timepoint(s) of evaluation of this end point: 2 months;Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactDépartement Promotion

CHU de Nantes

laetitia.biron@chu-nantes.fr033253482835

Outcome results